Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $2.0 million.

  • Jaguar Health's Cost of Revenue fell 64.68% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 4861.71%. This contributed to the annual value of $7.7 million for FY2024, which is 1907.12% up from last year.
  • Jaguar Health's Cost of Revenue amounted to $2.0 million in Q3 2025, which was down 64.68% from $2.5 million recorded in Q2 2025.
  • Jaguar Health's Cost of Revenue's 5-year high stood at $2.8 million during Q1 2022, with a 5-year trough of $1.4 million in Q1 2024.
  • For the 5-year period, Jaguar Health's Cost of Revenue averaged around $2.0 million, with its median value being $2.1 million (2022).
  • Its Cost of Revenue has fluctuated over the past 5 years, first crashed by 3354.5% in 2023, then surged by 7733.51% in 2024.
  • Jaguar Health's Cost of Revenue (Quarter) stood at $2.3 million in 2021, then dropped by 23.93% to $1.7 million in 2022, then dropped by 12.41% to $1.5 million in 2023, then soared by 77.34% to $2.7 million in 2024, then decreased by 26.45% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $2.5 million for Q2 2025, and $2.5 million during Q1 2025.